13G Filing: Sabby Capital and Taxus Cardium Pharmaceuticals Group Inc. (CRXM)

Page 5 of 8 – SEC Filing

Item 4.
Ownership.

Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in
Item 1.

(a)
Amount beneficially owned:

Sabby Healthcare Master Fund, Ltd. – 1,435,917

Sabby Management, LLC – 1,435,917

Hal Mintz – 1,435,917

(b)
Percent of class:

Sabby Healthcare Master Fund, Ltd. – 9.99%

Sabby Management, LLC – 9.99%

Hal Mintz – 9.99%(c)
Number of shares as to which the person has:

Sabby Healthcare Master Fund, Ltd.

(i)
Sole power to vote or to direct the vote
0
,(ii)
Shared power to vote or to direct the vote
1,435,917
,(iii)
Sole power to dispose or to direct the disposition of
0
,(iv)
Shared power to dispose or to direct the disposition of
1,435,917
.Sabby Management, LLC

(i)
Sole power to vote or to direct the vote
0
,(ii)
Shared power to vote or to direct the vote
1,435,917
,(iii)
Sole power to dispose or to direct the disposition of
0
,(iv)
Shared power to dispose or to direct the disposition of
1,435,917
.

Follow Gene Biotherapeutics Inc. (OTCMKTS:CRXM)